SciCombinator

Discover the most talked about and latest scientific content & concepts.

M Fleseriu, R Pivonello, J Young, AH Hamrahian, ME Molitch, C Shimizu, T Tanaka, A Shimatsu, T White, A Hilliard, C Tian, N Sauter, BM Biller and X Bertagna
Abstract
In a 10-week proof-of-concept study (LINC 1), the potent oral 11β-hydroxylase inhibitor osilodrostat (LCI699) normalized urinary free cortisol (UFC) in 11/12 patients with Cushing’s disease. The current 22-week study (LINC 2; NCT01331239) further evaluated osilodrostat in patients with Cushing’s disease.
Tweets*
10
Facebook likes*
0
Reddit*
0
News coverage*
2
Blogs*
0
SC clicks
0
Concepts
Zona fasciculata, Corticosteroid, Hypertension, Glucocorticoid, Cushing's syndrome, Cortisol
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com